Clover Biopharmaceuticals, Ltd. (HKG:2197)
Hong Kong
· Delayed Price · Currency is HKD 0.2400
-0.0030 (-1.23%)
May 30, 2025, 3:50 PM HKT
Clover Biopharmaceuticals Revenue
In the year 2024, Clover Biopharmaceuticals had annual revenue of 38.42M CNY, down -2.13%. Clover Biopharmaceuticals had revenue of 48.52M in the half year ending December 31, 2024.
Revenue
38.42M CNY
Revenue Growth
-2.13%
P/S Ratio
7.61
Revenue / Employee
128.06K CNY
Employees
300
Market Cap
311.29M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 32.53B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |
| Sino Biopharmaceutical | 30.72B |
| Akeso | 2.26B |